Academic and clinical certifications

2001

 

1-     Peter Furness,. Al B. Barqawi, Geoffrey Bisignani. Ross M. Decter. .KLIPPEL-TRENAUNAY SYNDROME: 2 CASE REPORTS AND A REVIEW OF GENITOURINARY MANIFESTATIONS. J Urol; 166: 1418-1420, 2001

 

2002

 

2-     Al B. Barqawi, Peter Furness, Martin Koyle. LAPARASCOPIC VARICOCELECTOMY INADOLESCENCE IS SAFE POST IPSILATERAL INGUINAL SURGERY. BJU International 89:269-272, 2002.

 

3-     Jamie B. Lowe, Peter D. Furness III, Al B. Barqawi, Martin A. Koyle, SURGICAL MANAGEMENT OF THE NEUROPATHIC BLADDER. Seminars in Ped. Surg, Vol. 11, No 2 (May), 2002 120-7

 

4-     Martin Koyle, Peter Furness. Al B. Barqawi.  LAPAROSCOPIC PALOMO VARICOCELE LIGATION IN CHILDREN AND ADOLESCENTS Pediatric Endosurgery & Innovative Techniques, Vol. 6(1), 2002. 15-9

 

5-     Paramjit S Chandhoke., Al B. Barqawi., Ronald A,. Chee-Awai, Carol Wernecke, Paulette H. Cohrs, And Jie Fan. A RANDOMIZED OUTCOMES TRIAL OF URETERAL STENTS FOR EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY OF SOLITARY KIDNEY OR PROXIMAL URETERAL STONES. J Urol; 167: 1981-1983, 2002

 

6-     Daneshgari, F.; Handel, L.; Banerjee, A., and Al B. Barqawi. ALTERATION IN THE TISSUE AND SIGNAL TRANSDUCTION CHARACTERISTICS OF THE BLADDER MAY BE RESPONSIBLE FOR ITS SUSCEPTIBILITY TO RECURRENT INFECTIONS IN DIABETES. BJU International - Supplement. 2002 Sep; 90 (Supplement 2):26.

 

7-     Daneshgari, F.; Mascha, E.; DeAntoni, E., and Al B. Barqawi. PRIMARY CARE PHYSICIAN ASSESSMENT OF PREVALENCE OF BLADDER CONTROL PROBLEMS IN A MULTI-ETHNIC POPULATION. BJU International - Supplement. 2002 Sep; 90 (Supplement 2):287.

 

8-     Koyle, M, Al B. Barqawi, Sorensen, C., and Krishnamurthy, M. USE OF THE DEFUNCTIONALIZED COLON (HARTMAN'S POUCH) IN PATIENTS WITH PERMANENT COLOSTOMIES FOR CONTINENT URINARY RECONSTRUCTION. BJU International - Supplement. 2002 Sep; 90 (Supplement 2):212.

 

9-     Edward Kim, Al B. Barqawi, Randall Meacham. APOPTOSIS: IT’S IMPORTANCE IN SPERMATOGENIC DYSFUNCTION. Urol Clin North Am. 2002 Nov; 29(4):755-65, vii.    

 

10- Al B. Barqawi, Peter Furness, Abelardo Errojan, Martin Koyle. THE MITROFANOFF PRINCIPLE AND VARIATIONS OF CONTINENT CUTANEOUS CATHETERIZABLE STOMAS. Infections in Urology; 2002 Nov, Vol. 15 (4): 3-12

 

2003

 

11- LiAnn. Handel, Al B. Barqawi, Peter D Furness, Martin A. Koyle. MALES WITH DOWN’S SYNDROME AND NONNEUROGENIC NEUROGENIC BLADDER. J Urol. 2003 Feb; 169(2):646-9.

 

12-  Peter Furness, Padraig Malone, Al B. Barqawi, Martin Koyle. THE MITROFANOFF PRINCIPLE: INNOVATIVE APPLICATIONS IN CONTINENT URINARY DIVERSIONS. Contemporary Urology 2003 Jan; Vol. 15 (1):30-45

 

13- Al B. Barqawi, Martin A Koyle, Bruce Blythe, Gerald H Jordan, Richard M Ehrlich. THE ROLE OF LAPAROSCOPY IN THE PATIENT WITH PREVIUOS NEGATIVE INGUINAL EXPLORATION FOR IMPALPABLE TESTIS Urology 2003 June; Vol. 61/6 pp 1234 – 1237

 

14- Al B. Barqawi and E. David Crawford. CURRENT OPTIONS FOR TREATMENT OF PROSTATE CANCER AFTER BIOCHEMICAL FAILURE OF PRIMARY THERAPY. New Urology Journal 2003 Vol. 1(1) pp 1-7 http://www.newurology.com/prostate/index.aspx

 

15- Michael Glode, Al B. Barqawi, Francis Crighton, Robert Kerbel, E. David Crawford. METRONOMIC THERAPY WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE FOR PROSTATE CANCER:  A PHASE II CLINICAL TRIAL.  Cancer 2003 October, 98(8):1643-8.  

 

16- Al B. Barqawi, Judd Moul, Ali Ziada, LiANN Handel, David E. Crawford, THE EFFICACY AND TOLERABILITY OF A COMBINATION OF FINASTERIDE AND LOW DOSE FLUTAMIDE FOR PSA-ONLY RECURRENCE AFTER DEFINITIVE THERAPY. Urology 2003 Nov, Vol. 62/5 pp 872-876

 

17- Al B. Barqawi, Bulent Akduman, Zinelabidine Abouelfadel, Monica Robischon, E. David Crawford PHASE II TRIAL FOR THE USE OF FLUTAMIDE AS A SINGLE ANTIANDROGEN TREATMENT OF HORMONE REFRACTORY PROSTATE CANCER. BJU International. 2003 Nov; 92(7):695

 

18- Martin Koyle, Al B. Barqawi, Jody Wild, Michelle Passamaneck , Peter Furness 3rd. PEDIATRIC URINARY TRACT INFECTIONS: THE ROLE OF FLUOROQUINOLONES. Pediatr Infect Dis J. 2003 Dec; 22(12):1133-1137.

 

2004

 

19- Al B. Barqawi, Anthony Caruso, Randall Meacham, EXPERIMENTAL VARICOCELE INDUCES TESTICULAR GERM CELL APOPTOSIS.  J Urol. 2004 Jan; 171(1):501-3.

 

20- Al B. Barqawi, Ian Thompson, E. David Crawford CHEMOPREVENTION OF PROSTATE CANCER; A REVIEW OF CLINICAL TRIALS IN THE US. J Urol. 2004 Feb: 171 (2):S5-S9

 

21- Al B. Barqawi, Ed Gamito, Colin O’Donnell, E. David Crawford. HERBAL AND VITAMIN SUPPLEMENT USE IN A PROSTATE CANCER SCREENING POPULATION.  Urology Volume 63, Issue 2 , February 2004, Pages 288-292

 

22- Al B. Barqawi, Richard Walsh, Randall Meacham, THE EFFECT OF PROLONGED CRYPTORCHIDISM ON GERM CELL APOPTOSIS AND TESTICULAR SPERM CONTENT IN RATS. Asian J. Andrology 2004 Mar;6(1):47-51.

 

23- Ali M. Ziada, Al B. Barqawi, Madeleine Kane, Susan Majeski, Marileila Varella-Garcia, Lin Chen, David E. Crawford,  Michael Glode.  PHASE II TRIAL: THE USE OF HERCEPTIN® IN THE TREATMENT OF HORMONE REFRACTORY PROSTATE CANCER. Prostate. 2004 Sep 1; 60(4):332-7.

 

24- McManus MC, Al B. Barqawi, Meacham RB, Furness III PD, Koyle MA: LAPAROSCOPIC VARICOCELE LIGATION: ARE THERE ADVANTAGES COMPARED TO THE MICROSCOPIC SUBINGUINAL APPROACH?  Urology Vol. 64/2, 2004 pp 357-360

 

25-  E David Crawford, Al B. Barqawi.  INTERMEDIATE-TO HIGH-RISK PROSTATE CANCER PATIENT TREATED WITH RADIATION THERAPY. Oncology (Huntingt). 2004 Aug;18(9):1105-10.

 

26- Al B. Barqawi, Peter Furness III, Martin Koyle. LESSONS LEARNED FROM CHILDREN WITH CATHTERIZABLE STOMAS.  BJU International 2004 Dec; 94, 1344-47,

 

27- Martin A. Koyle, Siam Oottamasathien, Al B. Barqawi, Ashok Rajimwale, Peter D. Furness III LAPAROSCOPIC PALOMO VARICOCELE LIGATION IN CHILDREN AND ADOLESCENTS: RESULTS OF 103 CASES  J Urol. 2004 Oct;172(4 Pt 2):1749-52; discussion 1752.

2005

 

28- Al B. Barqawi and E. David Crawford. FOCAL THERAPY IN PROSTATE CANCER: FUTURE TRENDS. BJU International. 2005 Feb;95(3):273-4.

 

29- Al B. Barqawi, Brian Golden, Colin O’Donnell, E. David Crawford THE OBSERVED TPSA/CPSA CORRELATION WITH AGE AND OBESITY; ANALYSIS FROM THE PROSTATE CANCER AWARENESS WEEK (PCAW) Urology. 2005 Apr;65(4):708-12.

 

30- Ravi Kumar, Al B. Barqawi, E. David Crawford. Epidemiology of prostate cancer. Published by US Urology Journal on-line www.bbriefings.com/pdf/1033/Crawford.pdf

 

31- Ravi Kumar, Al B. Barqawi, E. David Crawford. PREVENTING AND TREATING THE COMPLICATIONS OF HORMONE THERAPY. Curr Urol Rep. 2005 May;6(3):217-23.

 

32- Al B. Barqawi, E. David Crawford. TESTOSTERONE REPLACEMENT THERAPY AND THE RISK OF PROSTATE CANCER. A PERSPECTIVE REVIEW Int J Impot Res. 2005 May 12; [Epub ahead of print]

 

33- Al B. Barqawi, Colin O’Donnell, E. David Crawford THE EFFECT OF LUTS ON ERECTILE DYSFUNCTION IN THE AGING MALE; ANALYSIS FROM THE PROSTATE CANCER AWARENESS WEEK Int J Impot Res. 2005 Jul-Aug;17(4):370-4

 

34- William DeFoor, Eugene Minevich, Al B. Barqawi, David Kitchens, Curtis Sheldon, and Martin Koyle. Perforation of Continent Cecostomy (ACE): Diagnosis and Management. . J Urol. 2005 Oct; 174(4, Part 2 of 2):1644-1646.

 

35- Ravi Kumar, Al B. Barqawi, E. David Crawford. ADVERSE EVENTS ASSOCIATED WITH HORMONAL THERAPY OF PROSTATE CANCER. Reviews in Urology July 2005;7( 5): 144-149

 

36- Jesse Mills, Al B. Barqawi, Hari Koul, Randall Meacham. THE MOLECULAR BASIS OF ERECTILE DYSFUNCTION; FROM BENCH TO BEDSIDE. Reviews in Urology August 2005;7(3):128-134

 

37- Al B. Barqawi, E. David Crawford. TESTOSTERONE REPLACEMENT THERAPY AND PROSTATE CANCER (STATE OF THE ART). International Journal of impotence research 2005 Nov 10

 

38- Bulent Akduman Al B. Barqawi, E. David Crawford MINIMALLY INVASIVE SURGERY IN PROSTATE CANCER:  CURRENT AND - FUTURE  PERSPECTIVES. Cancer J. 2005 Sep-Oct;11 (5):355-61.

 

39- Al B. Barqawi, E. David Crawford. THE IMPACT OF TESTOSTERONE LEVELS ON MEN'S HEALTH, SHOULD WE WORRY? Aging health journal. October 2005. Vol. 1 No 2: 253-261

 

40- Al B. Barqawi.  Minimally invasive treatment (MIT) in cancer. Cancer J. 2005 May-Jun;11(3):252. letter to the editor

 

 

2006

 

41- Tom Flaig, Al B. Barqawi, Bernie Pistone, E. David Crawford, L. Michael Glode A PHASE II TRIAL OF THE USE OF A COMBINATION OF DEXAMETHASONE AND CARBOPLATIN FOLLOWING 1Α, 25-DIHYDROXYVITAMIN D SUPPLEMENT IN PATIENTS WITH HORMONE REFRACTORY PROSTATE CANCER. CANCER 2006 Jul 15;107(2):266-74

 

42- Al B. Barqawi. E. David Crawford. RE: PROSTATE CANCER IN MEN USING TESTOSTERONE SUPPLEMENTATION. F. D. Gaylis, D. W. Lin, J. M. Ignatoff, C. L. Amling, R. F. Tutrone and D. J. Cosgrove. J Urol. 2006 Apr;175(4):1572-3; author reply 1573

 

43- Al B. Barqawi. TESTOSTERONE REPLACEMENT THERAPY: THE EFFECT ON QUALITY OF LIFE AND THE RISK OF PROSTATIC DISEASE. Grand Round In Urology. 2006 Volume 4, Issue 3, 11- 15. 

 

2007

 

44- E. David Crawford, Al B. Barqawi TARGETED FOCAL THERAPY OF PROSTATE CANCER USING MINIMALLY INVASIVE THERAPY. Oncology,  Vol. 21, Number 1, Page 27-39 January 2007

 

45- E. David Crawford, Al B. Barqawi, Colin O’Donnell, Abraham Morgentaler. THE DIURNAL VARIATION OF  SERUM TESTOSTERONE LEVELS IN THE AGING MALE  BJU International, BJU Int. 2007 Jul 31;100(3):509-513. Epub 2007 Jun 6.

 

46- Al B. Barqawi, Colin O’Donnell, E. David Crawford THE PREVALENCE OF ALPHA-BLOCKER INTAKE AND ITS APPERANT EFFECT ON LUTS AND ERECTILE DYSFUCTION IN A SCREENING POPULATION. BJU Int. 2007 Oct;100(4):853-7. Epub 2007 Jul 23.

 

47- Flaig T, Crawford ED, Kavanagh B, Lucia S, La Rosa F, Barqawi Al B, Crighton F, Glode LM. PROSTATE CANCER IN A MAN WITH MULTIPLE PREVIOUS CANCERS. Oncology (Williston Park). 2007 Apr;21(5):611-4.

 

48- Al B. Barqawi, J. Lugg, E. D. Crawford TARGET FOCAL THERAPY IN EARLY PROSTATE CANCER: INITIAL SINGLE INSTITUTION RESULTS. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 15574

 

49- Bostwick DG, Waters DJ, Farley ER, Meiers I, Rukstalis D, Cavanaugh WA, Ragde H, Dineen MK, Bahn D, Scionti S, Babian R, Ellis DS, Rewcastle JC, Burke HB, Andriole GL, Onik G, Barqawi AE, Maksem J, Barzell WE.Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006.Urology. 2007 Dec;70(6 Suppl):42-4. No abstract available.

 

50- Huang Z, Chen Q, Dole KC, Barqawi AB, Chen YK, Blanc D, Wilson BC, Hetzel FW.

The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model.Photochem Photobiol Sci. 2007 Dec;6(12):1318-24. Epub 2007 Aug 22.

 

51- Barqawi AB, Lu L, Crawford ED, Fenster A, Werahera PN, Kumar D, Miller S, Suri JS.Three different strategies for real-time prostate capsule volume computation from 3-D end-fire transrectal ultrasound.Conf Proc IEEE Eng Med Biol Soc. 2007;2007:816-8.

 

52- Barqawi AB, Crawford ED.The current use and future trends of focal surgical therapy in the management of localized prostate cancer.Cancer J. 2007 Sep-Oct;13(5):313-7. Review.

 

 

2008

 

53- Joseph Dall’Era, Lauren N. Byrne, Al B. Barqawi. THE USE OF FINASTERIDE PLUS DOXAZOSIN COMBINATION THERAPY FOR TREATMENT OF LOWER URINARY SYMPTOMS RELATED TO BENIGN PROSTATIC HYPERPLASIA:  APPLICATIONS IN THE AGING POPULATION. Aging Health: Drug evaluation. Ahead of print 2008

 

54- Al B. Barqawi, Lu L, Crawford ED, Fenster A, Werahera PN, Kumar D, Miller S, Suri JS. THREE DIFFERENT STRATEGIES FOR REAL-TIME PROSTATE CAPSULE VOLUME COMPUTATION FROM 3-D END-FIRE TRANSRECTAL ULTRASOUND. Conf Proc IEEE Eng Med Biol Soc. 2007;1:816-8.

 

55- Al B. Barqawi, E. David Crawford.  INTRAPROSTATIC INJECTION OF BOTULINUM TOXIN FOR THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA. PHASE I/II. Current Prostate Reports 2008, 6: 117 – 122

 

56- Bostwick DG, Waters DJ, Farley ER, Meiers I, Rukstalis D, Cavanaugh WA, Ragde H, Dineen MK, Bahn D, Scionti S, Babian R, Ellis DS, Rewcastle JC, Burke HB, Andriole GL, Onik G, Al B. Barqawi, Maksem J, Barzell WE. GROUP CONSENSUS REPORTS FROM THE CONSENSUS CONFERENCE ON FOCAL TREATMENT OF PROSTATIC CARCINOMA. Urology. 2007 Dec;70(6 Suppl):42-4.

 

57- Al B. Barqawi, E. David Crawford. CONTROVERSIES IN THE USE OF FOCAL THERAPY FOR LOCALIZED PROSTATE CANCER: CRYOTHERAPY VS. HIGH INTENSITY FOCUSED ULTRASOUND VS. BRACHYTHERAPY Accepted, Current Urology Reports. 2008

 

58- Narayanan R, Werahera PN, Barqawi A, Crawford ED, Shinohara K, Simoneau AR, Suri JS.Adaptation of a 3D prostate cancer atlas for transrectal ultrasound guided target-specific biopsy.Phys Med Biol. 2008 Oct 21;53(20):N397-406. Epub 2008 Sep 30.

 

59- Huang Z, Xu H, Meyers AD, Musani AI, Wang L, Tagg R, Barqawi AB, Chen YK.Photodynamic therapy for treatment of solid tumors--potential and technical challenges.Technol Cancer Res Treat. 2008 Aug;7(4):309-20. Review.

 

60- Shen F, Shinohara K, Kumar D, Khemka A, Simoneau AR, Werahera PN, Li L, Guo Y, Narayanan R, Wei L, Barqawi A, Crawford ED, Davatzikos C, Suri JS.Three-dimensional sonography with needle tracking: role in diagnosis and treatment of prostate cancer.J Ultrasound Med. 2008 Jun;27(6):895-905. Review.

 

61- Barqawi AB, Crawford ED.Emerging role of HIFU as a noninvasive ablative method to treat localized prostate cancer.Oncology (Williston Park). 2008 Feb;22(2):123-9; discussion 129, 133, 137 passim. Review

 

2009

 

62- Siomos VJ, La Rosa FG, Flaig TW, Kondo KL, Mitchell JD, Wilson S, Barqawi AB.Recurrent urothelial carcinoma with pulmonary metastasis.Oncology (Williston Park). 2009 Dec;23(14):1301-4. No abstract available.

 

63- Hou AH, Swanson D, Barqawi AB.Modalities for imaging of prostate cancer.Adv Urol. 2009:818065. Epub 2010 Mar 17

2010

 

64- Barqawi AB, O'Donnell CI, Siomos VJ, Hou AH.The effect of short-term dutasteride intake in early-stage prostate cancer: analysis of 148 patients who underwent three-dimensional prostate mapping biopsy.Urology. 2010 Nov;76(5):1067-71. Epub 2010 May 15.

 

65- Barqawi AB.Editorial comment.J Urol. 2010 Apr;183(4):1353; discussion 1354. Epub 2010 Feb 19. No abstract available.

 

  1. Al B. Barqawia Editorial Comments Plasma Volume Changes Affect Prostate Specific Antigen in Healthy Men 19 February 2010. 

 

2011

 

67- Fronczak CM, Kim ED, Barqawi AB.The Insults of Recreational Drug Abuse on Male Fertility.J Androl. 2011 Jul 28.

 

68- Crawford ED, O'Donnell CI, Barqawi AB, O'Leary M, Sullivan KF, Hughes A, Roehrborn CG, Maroni P.Validation of the modified american urological association symptom score.J Urol. 2011 Sep;186(3):945-8. Epub 2011 Jul 24.

 

69- Barqawi AB, Sullivan KF, Crawford ED, Roehrborn CG, Hughes A, O'Leary M, Stone N, O'Donnell CI.Methods of Developing UWIN, the Modified American Urological Association Symptom Score.J Urol. 2011 Sep;186(3):940-4. Epub 2011 Jul 24.

 

70- Barqawi AB, Turcanu R, Gamito EJ, Lucia SM, O'Donnell CI, Crawford ED, La Rosa DD, La Rosa FG.The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancer.Int J Clin Exp Pathol. 2011 Jun 20;4(5):468-75.

 

71- The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer.Barqawi AB, Rove KO, Gholizadeh S, O'Donnell CI, Koul H, Crawford ED.J Urol. 2011 Jul;186(1):80-5. Epub 2011 May 14.

 

72- Siomos VJ, Barqawi A.The current status of cryotherapy and high-intensity focused ultrasound in the treatment of low-grade prostate cancer.Rev Recent Clin Trials. 2011 May;6(2):171-6.

 

73- Philips J,   Barqawi A.   CHEMOPREVENTION IN PROSTATE CANCER Published, In Press, Radiation Medicine Rounds, 2011

 

2012

 

74-  Barqawi AB, Krughoff KJ, Eid K. CURRENT CHALLENGES IN PROSTATE CANCER MANAGEMENT AND THE RATIONALE BEHIND TARGETED FOCAL THERAPY. Adv Urol. 2012;2012: Epub 2012 May

 

75- Crawford ED, Rove KO, Barqawi A, Maroni PD, Werahera PN, Baer CA, Koul HK, Rove CA, Lucia MS, La Rosa FG   Clinical-Pathologic Correlation Between Transperineal Mapping Biopsies of the Prostate and Three-Dimensional Reconstruction of Prostatectomy Specimens. Prostate. 2012 Nov 20.pros.22622.

 

76- Fronczak CM, Kim ED, Barqawi AB The insults of illicit drug use on male fertility. J Androl. 2012 Jul-Aug;33(4):515-28. doi: 10.2164/jandrol.110.011874. Epub 2011 Jul 28. Review.

 

77- Daniel Smith, Diliana Stoimenova, Khadijah Eid and Al B. Barqawi. The role of targeted focal therapy in the management of low risk prostate cancer, update on current challenges," Prostate Cancer. 2012;2012:587139. Epub 2012 Dec 31

 

 

2013

 

 

78- Vigen R, O'Donnell CI, Barón AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, Rumsfeld JS, Ho PM. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.JAMA. 2013 Nov 6;310(17):1829-36. doi: 10.1001/jama.2013.280386.

 

79- Eid K, Krughoff K, Stoimenova D, Smith D, Phillips J, O'Donnell C, Barqawi A. Validation of the Urgency, Weak Stream, Incomplete Emptying, and Nocturia (UWIN) Score Compared With the American Urological Association Symptoms Score in Assessing Lower Urinary Tract Symptoms in the Clinical Setting. Urology. 2013 Oct 15. doi:pii: S0090-4295(13)01120-5. 10.1016/j.urology.2013.08.039. [Epub ahead of print]

 

80- Barqawi AB. Editorial comment. Complications and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapy. Urology. 2013 Jun;81(6):1296. doi: 10.1016/j.urology.2012.11.079. Epub 2013 Mar 19. No abstract available.

 

 

2014

 

 

81- Barqawi AB, Stoimenova D, Krughoff K, Eid K, O'Donnell C, Phillips JM, Crawford ED.

Targeted Focal Therapy in the Management of Organ-Confined Prostate Cancer. J Urol. 2014 Mar 15. pii: S0022-5347(14)02950-4

 

82- Krughoff K, Eid K, Phillips J, Stoimenova D, Smith D, O'Donnell C, Crawford ED, Barqawi A.    The accuracy of prostate cancer localization diagnosed on transrectal ultrasound-guided biopsy compared to 3-dimensional transperineal approach.    Adv Urol. 2013;2013:249080 Epub 2013 Dec 29.

 

83- Jason Philip, Kevin Krughoff and A. Barqawi. Cryotherapy In Prostate Cancer, Journal of Clinical Urology February 3, 2014 2051415814521806

 

84-     Crawford Kyle Nelson§ M. Scott Lucia‖ Barqawi Francisco Moving Forward the State of the Art in Prostate Cancer Treatment: Targeted Focal Therapy Urology Practice, the official journal of AUA September 2014 Volume 1, Issue 3, Pages 156–164

85- Barqawi et al. Initial Experience of Targeted Focal Interstitial Laser Ablation of Prostate Cancer with MRI Guidance Curr Urol 2015;8:199–207

 

86- Emma Huebner and Al Barqawi   The current challenges in the management of prostate cancer and emerging treatment options. Biomedical Sciences 2015

Book chapters and learning video chapters

  • PROSTATE CANCER DIAGNOSIS: PSA, BIOPSY, AND BEYOND, edited by:  J. Stephen Jones, MD, FACS, MBA, CHAPTER 17: Section Three Prostate Biopsy: Optimizing the procedure, Transperineal biopsy. Vassilis J Siomos MD, E David Crawford MD, and Al Barqawi MD

  • CHEMOPREVENTION IN PROSTATE CANCER edited by SIRINJAM, Jason Philips MD and Al Barqawi MD

  • FOCAL THERAPY IN PROSTATE CANCER, edited by Manit Arya, Mark Emberton, Peter R. Carroll, Hashim U. Ahmed. Chapter 12. Determining Success of Focal Therapy: Biochemical and Biopsy Strategies (In press) Al Barqawi MD, Paul Maroni MD

  • PROSTATE CANCER: SURGICAL PRINCIPLES AND PRACTICE, SECTION F. TREATMENT OF EARLY STAGE PROSTATE CANCER. Chapter 29. Androgen Deprivation for the Treatment of Prostate Cancer: General Principles; Al B. Barqawi and David G. McLeod

  • Minimal Access Radical Prostatectomy. Al B. Barqawi and E. David Crawford

Make an appointment  1-720-848-1800

12631 East 17th Ave., Room L15-5602,

Academic Office One Bldg. MS C-319
Aurora, CO 80045


ph: 720-848-1800
fax: 303-724-2818
alt: 303-724-2722

© Copyright 2017 Al Barqawi MD

  • w-facebook
  • White Google+ Icon